drugset / Trial / NCT02760043

Dexamethasone in Total Knee and Total Hip Arthroplasty

NCT02760043

Phase 2/3 Unknown 314 enrolled University Health Network, Toronto
RandomizedParallel-groupTriple-blindSupportive care

Summary

This study will evaluate if the addition of dexamethasone to a local infiltration analgesia mixture will improve functional outcomes following total hip and knee arthroplasty.

Timeline

Start
2016-04
Primary completion
2018-10
Completion
2018-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 8 mg
Background Epinephrine Other / unclassified 0.6 mg
Background Ketorolac Other / unclassified 30 mg
Background Ropivacaine Other / unclassified 2 %

Indications